ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,687 Cr | ₹2,514 Cr | ₹1,520 Cr | ₹1,641 Cr | ₹1,831 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹2,687 Cr |
| Mar2025 | ₹2,514 Cr |
| Mar2024 | ₹1,520 Cr |
| Mar2023 | ₹1,641 Cr |
| Mar2022 | ₹1,831 Cr |
How is Total Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,687 Cr | 6.86 | |
| Mar2025 | ₹2,514 Cr | 65.38 | |
| Mar2024 | ₹1,520 Cr | -7.35 | |
| Mar2023 | ₹1,641 Cr | -10.37 | |
| Mar2022 | ₹1,831 Cr | - | |
Compare Total Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹15,670.0 Cr | -2.1% | -2.2% | -21.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -2.1% |
-2.2% |
-21.2% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses